图片名称

Focusfreda Sodium Hyaluronate API obtained EU export qualification


Recently, after strict examination and evaluation, Focusfreda Sodium Hyaluronate API has successfully obtained the export certificate (WC certification) issued by Shandong Drug Administration, which shows that the pharmaceutical production quality system of the enterprise meets GMP requirements and is qualified to export to the European market.

 

 

The approval this time is another major breakthrough in the strategic transformation and upgrading of the high-end pharmaceutical industry of Focusfreda raw materials plate after obtaining the registration number of DMF in the United States, the registration number of CDE "I" of eye drop-grade sodium hyaluronate pharmaceutical excipients, the CEP certificate of EU raw materials, and the registration number of CDE "I" of eye drop-grade sodium hyaluronate raw materials, and successfully carrying out on-site inspection of drug registration and GMP compliance inspection, laying a solid foundation for enterprises to further expand the European market and deepen international cooperation.

 

 

In recent years, Focusfreda has successively established high-quality scientific research and development teams with many well-known universities and R&D institutions, established scientific research and production consortia, and obtained a number of invention patents. The products have been widely recognized in the market and exported to more than 70 countries and regions, and have been applied in the fields of cosmetics, medical beauty, medicines and nutrition and health products. With the deepening of technology research and development and the gradual upgrading of quality, Focusfreda's export business has been further expanded, the strategic transformation and upgrading to high-end pharmaceutical industry has been steadily promoted, and its reputation and competitiveness in the international market have been continuously improved.

In the future, Focusfreda will continue to focus on the innovative research and development of sodium hyaluronate, adhere to the principle of "quality first, customer first", continue to optimize product quality and service experience, adhere to the development policy of "going global", bring more excellent and efficient solutions to customers around the world, and cultivate new kinetic energy for high-quality development of enterprises with high-level international trade.

Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner

CONTACT US

Tel:+86-0537-3195566
E-mail:sales@focuschem.com
Add:Economic Development Zone, High-speed Railway New District, Qufu City, Jining City, Shandong Province, China

图片名称

WeChat


Copyright © 2022  Shandong Focusfreda Biotech Co., Ltd.   鲁ICP备2021008509号-2   Powerby  :   300.cn   jinan​   SEO